These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10965489)

  • 1. [Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
    Castellote J; Porta F
    Med Clin (Barc); 2000 Jun; 115(3):118-9. PubMed ID: 10965489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Helicobacter pylori infections].
    Calvet Calvo X
    Gastroenterol Hepatol; 1998 Apr; 21(4):203-6. PubMed ID: 9633184
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating Helicobacter pylori.
    Howden CW; Hunt RH
    Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
    Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy and Helicobacter pylori.
    Davis S
    Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection.
    Savarino V; Vigneri S
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1251-2. PubMed ID: 10468709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population.
    Uygun A; Kadayifci A; Kilinc R; Dagalp K
    Am J Gastroenterol; 1999 Oct; 94(10):3073-4. PubMed ID: 10520880
    [No Abstract]   [Full Text] [Related]  

  • 16. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP; Gonzalez L; Calvet X
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin].
    Rodrigo Sáez L; Fernández Cadenas F; Lomo Montero J; García Calero C; García Saavedra L
    Rev Esp Enferm Dig; 1997 Feb; 89(2):146-7. PubMed ID: 9115827
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.